RETRACTION: miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer

撤稿声明:miR-664a-3p通过靶向Hippo通路在胃癌发展中发挥癌基因作用

阅读:1

Abstract

L. Wang, B. Li, L. Zhang, Q. Li, Z. He, X. Zhang, X. Huang, Z. Xu, Y. Xia, Q. Zhang, Q. Li, J. Xu, G. Sun, Z. Xu, "miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer," Cell Proliferation 52, no. 3 (2019): e12567, https://doi.org/10.1111/cpr.12567. The above article, published online on 18 March 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Qi Zhou, and John Wiley and Sons Ltd. Following publication, concerns were raised by third parties regarding suspected duplication of figures 2c, 2d, 4g, 4h and 5a. The authors explained that the duplicates were a result of negligence during data storage. Due to the extent and nature of the mistakes made, the editors have lost confidence in the results and conclusions of this study.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。